Vivos Therapeutics, Inc. Deferred Revenue
Vivos Therapeutics, Inc. (VVOS) had Deferred Revenue of $600.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2026-08-14
- 2026-06-30: Deferred Revenue, Current $600.00K.
- 2026-03-31: Deferred Revenue, Current $500.00K.
- 2025-12-31: Deferred Revenue, Current $500.00K.
- 2025-09-30: Deferred Revenue, Current $500.00K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2026-06-30 | $600.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $500.00K 10-Q · filed 2026-05-20 |
| 2025-12-31 | $500.00K 10-K · filed 2026-04-15 |
| 2025-09-30 | $500.00K 10-Q · filed 2025-11-19 |
| 2025-06-30 | $500.00K 10-Q · filed 2025-08-19 |
| 2025-03-31 | $600.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $900.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | $1.30M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.80M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.40M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $2.10M 10-K/A · filed 2024-07-30 |
| 2023-09-30 | $2.40M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $2.40M 10-Q · filed 2023-08-16 |
| 2023-03-31 | $2.60M 10-Q · filed 2023-06-08 |
| 2022-12-31 | $2.90M 10-K · filed 2023-03-30 |
| 2022-09-30 | $2.40M 10-Q · filed 2022-12-20 |
| 2022-06-30 | $2.10M 10-Q · filed 2022-12-20 |
| 2022-03-31 | $1.80M 10-Q/A · filed 2022-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |